bleuacacia ltd Warrants
bleuacacia ltd does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of premium branded consumer retail. The company was incorporated in 2021 and is based in New York, New York.
bleuacacia ltd Warrants (BLEUW) - Net Assets
Latest net assets as of March 2024: $-4.74 Million USD
Based on the latest financial reports, bleuacacia ltd Warrants (BLEUW) has net assets worth $-4.74 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.18 Million) and total liabilities ($11.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.74 Million |
| % of Total Assets | -66.04% |
| Annual Growth Rate | -56.08% |
| 5-Year Change | -99.01% |
| 10-Year Change | N/A |
| Growth Volatility | 53.35 |
bleuacacia ltd Warrants - Net Assets Trend (2018–2023)
This chart illustrates how bleuacacia ltd Warrants's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for bleuacacia ltd Warrants (2018–2023)
The table below shows the annual net assets of bleuacacia ltd Warrants from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $5.60 Million | -97.92% |
| 2022-12-31 | $269.49 Million | +0.94% |
| 2021-12-31 | $266.98 Million | -23.35% |
| 2020-12-31 | $348.33 Million | -38.67% |
| 2019-12-31 | $567.96 Million | +65.86% |
| 2018-12-31 | $342.44 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to bleuacacia ltd Warrants's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 677.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $16.92 Million | 302.20% |
| Total Equity | $5.60 Million | 100.00% |
bleuacacia ltd Warrants Competitors by Market Cap
The table below lists competitors of bleuacacia ltd Warrants ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Triad Group PLC
LSE:TRD
|
$6.36K |
|
FHER3F
SA:FHER3F
|
$6.36K |
|
Finkurve Financial Services Limited
NSE:FINKURVE
|
$6.36K |
|
PERRIGO
F:PGO
|
$6.37K |
|
Ubion Co. Ltd.
KO:084440
|
$6.36K |
|
CPC
VN:CPC
|
$6.35K |
|
IROBOT
BE:I8R
|
$6.35K |
|
Orzel SA
WAR:ORL
|
$6.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in bleuacacia ltd Warrants's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 269,488,107 to 5,598,731, a change of -263,889,376 (-97.9%).
- Net income of 3,864,125 contributed positively to equity growth.
- Share repurchases of 267,753,501 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.86 Million | +69.02% |
| Share Repurchases | $267.75 Million | -4782.4% |
| Total Change | $- | -97.92% |
Book Value vs Market Value Analysis
This analysis compares bleuacacia ltd Warrants's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $15.01 | $0.01 | x |
| 2019-12-31 | $15.29 | $0.01 | x |
| 2020-12-31 | $14.54 | $0.01 | x |
| 2021-12-31 | $7.74 | $0.01 | x |
| 2022-12-31 | $7.81 | $0.01 | x |
| 2023-12-31 | $0.30 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently bleuacacia ltd Warrants utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 69.02%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 3.05x
- Recent ROE (69.02%) is above the historical average (13.83%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 1.07% | 92.49% | 0.01x | 1.65x | $-30.59 Million |
| 2019 | 8.57% | 99.03% | 0.05x | 1.60x | $-5.12 Million |
| 2020 | 2.27% | 96.29% | 0.01x | 1.65x | $-26.93 Million |
| 2021 | -0.10% | -0.74% | 0.13x | 1.04x | $-26.97 Million |
| 2022 | 2.19% | 0.00% | 0.00x | 1.04x | $-21.06 Million |
| 2023 | 69.02% | 0.00% | 0.00x | 3.05x | $3.30 Million |
Industry Comparison
This section compares bleuacacia ltd Warrants's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| bleuacacia ltd Warrants (BLEUW) | $-4.74 Million | 1.07% | N/A | $6.36K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |